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Introduction
While technical innovations and scientiﬁ c experiments 
often lead clinical practice, at times clinical science lags 
behind experience and simply documents what appears 
to be the fallacy or validity of ongoing practice. Progress 
made in this way can be slow, and imperfect theory may 
prove diﬃ  cult to challenge. What follows is a wide-
ranging set of unproven ideas, each having a defensible 
rationale but unveriﬁ ed worth. Th e intent of this thought-
provoking format is to stimulate thinking and inter-
change, and perhaps to point toward new directions with 
potential for productive research, conceptual modi ﬁ  ca-
tion, and eventual applications that could improve care of 
the critically ill. In what follows, a brief back ground 
outlines the rationale for each novel and unproven idea 
endorsed by the presenter.
We should retire the stethoscope
(J-L Vincent)
Background
Dating from the days of Laennec, the stethoscope has 
proven itself a robust and helpful diagnostic instrument 
[1]. Chief among the instrument’s attractive features are 
its portability, simplicity, ubiquity, low cost, and ability to 
complement the physical examination by opening an 
immediate acoustic window into the functional status of 
the lungs (for example, wheezes, rales) and heart (gallops, 
murmurs). It is a testimony to past contributions that this 
tool has not changed fundamentally in more than two 
centuries. Traditional stethoscopy does have drawbacks, 
however. Unrecorded sounds heard through the stetho-
scope are evanescent, the interpretation of the nature, 
timing, and amplitude of breath sounds is subjective, and 
high variability between observers is well documented 
[2]. Although acoustic information can be digitally pro-
cessed as well as displayed [3], traditional stethoscopic 
information is descriptive rather than quantitative. Th e 
value of auscultation (similar to the unaided physical 
examination) depends on the skill of the individual and 
the completeness of reporting [4].
Th e stethoscope was particularly useful as an aid for 
physical examination when bedside imaging either was 
not available or was diﬃ  cult to interpret. Not only do we 
now have better quality radiographs, but we also have 
echocardio graphy and ultrasound that can be quickly and 
repeatedly deployed to yield detailed and quantitative 
imaging infor mation [5]. Bed side computed tomography 
scanners and even magnetic resonance imagers are not 
far away from use. A continuous data-stream that yields 
dynamic functional monitoring may be aﬀ orded by 
emerg ing technologies such as electrical impedance 
tomography and acoustic monitoring. By comparison, 
the venerable stethoscope seems dated and crude [6].
Nonetheless, the no-cost, instantly available stetho-
scope will continue to have indications, especially when 
immediate availability and feedback are at a premium. 
For example, auscultation aids in making sure that an 
endotracheal tube is in the right track or not placed too 
far down (decreased breath sounds in one lung). Another 
use is the classiﬁ cation of very acute respiratory failure: Is 
the problem tube obstruction? Bronchospasm? Pneumo-
thorax? Hemothorax? While not deﬁ nitive, auscultation 
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may therefore eﬀ ectively complement more precise and 
detailed diagnostic methods [7].
Idea
Deploy quantitative, recordable, and detailed diagnostic 
and monitoring technologies at the bedside, while rele-
gat ing the stethoscope to a lesser screening role for 
speciﬁ c, targeted applications.
De-stressing therapy: blockade of the β-adrenergic 
system benefi ts mortality, metabolism, and the 
immune system
(M Singer)
Background
Our innate responses may be ill adapted to life-
threatening illness. One clear possibility is that the native 
hormonal reaction to such challenges may be noxious, 
perhaps even accelerating injury processes in the wrong 
direction [8,9]. Physiological adaptations to catastrophic 
and therefore unsurvivable conditions are not likely to 
have evolved naturally. One could even argue that 
evolution would have selected against those genes that 
would have allowed the organism to experience trauma, 
infection, or serious acute organ dysfunction. Even the 
ﬁ ght or ﬂ ight response may be excessive.
Overly exuberant upregulation of the β-adrenergic 
system in response to stresses of various types (for 
example, cardiovascular crises, sepsis, massive wound-
ing) has been shown to produce necrosis of vital tissues 
[10]. Published clinical trials demonstrate the potential 
for β-blockade to reduce myocardial damage following 
coronary occlusion. Sudden emotional stress may pro-
duce dramatic cardiac dysfunction, which persists for 
weeks afterwards (Takotsubo cardiomyopathy) [11]. β-
adrenergic blockade, while contraindicated during an 
acute attack, may reduce sensitivity to methacholine 
challenge in the setting of chronic asthmatic disease. 
Continuation of intense β-stimulation has the opposite 
eﬀ ect. β-blockade has experimentally been shown to 
improve survival in rats challenged with intravenous lipo-
polysaccharide, and β-blockers are most eﬀ ective if given 
before such a challenge [12]. Such observations suggest 
that interference with hardwired adrenergic responses to 
physiologic crises (such as severe sepsis) by modulation 
of their intensity could be a productive therapeutic 
avenue to pursue.
Idea
Rather than relying on high-dose catecholamine-based 
inotropic/vasoactive agents, using noncatechol inotropes 
(for example, milrinone) in conjunction with closely 
modulated β-blockade may be a rational approach to 
supporting the cardiovascular system during the stress of 
severe sepsis.
Anabolic/anti-catabolic therapy in critical illness 
(P Wischmeyer)
Background
Many patients survive the ICU only to face a protracted 
period of recovery, permanent disability, or eventual 
death from immobility. Recent data reveal more than 40% 
of the 6-month mortality following critical illness occurs 
after the patient has been discharged from the ICU [13]. 
Many of these deaths are believed to occur indirectly as a 
result of catabolism, loss of lean body mass, and lack of 
adequate physical activity, and to ultimately culminate in 
profound weakness and an inability to mobilize [14,15]. 
Many patients report very poor physical function for the 
entire ﬁ rst year following ICU discharge [14] and these 
physical dis abilities have been shown to persist for 
5 years or longer following the ICU discharge. Survivors 
of our advanced ICU care are thus often signiﬁ cantly 
debilitated for months or years afterwards  – a process 
known as ICU-acquired weakness. Many ICU survivors 
suﬀ er rapid, dramatic loss of lean body mass, causing 
signiﬁ cant debility that leaves them predisposed to 
aspiration, pneu monia, and other life-threatening com-
pli cations [15]. Th e patient facing the abrupt stresses 
imposed by critical illness has not had time to evolve 
appropriate – and in this case adap tive – responses.
Th e ICU experience undergone by many normal 
individuals is not unlike the stresses encountered by elite 
athletes during training and competition. Critical illness 
progresses through acute, chronic, and recovery phases, 
each with their diﬀ erent nutritional demands and 
suscepti bilities. Before competition, many of the most 
successful competitors take anabolic, performance-
enhancing agents for extended periods that allow them to 
cope with the stresses of performing exceptionally at the 
time of their events. Elite strength-training athletes 
legally utilize high-quality protein (typically 2.0 g/kg/day), 
glutamine, ﬁ sh oil (an anti-catabolic), hydroxy methyl 
butyrate, and creatine. As has been well described in the 
popular press in sports such as baseball and cycling, 
many athletes use nonsanctioned androgens (testos-
terone derivatives) and growth hormone, especially when 
trying to speed recovery after intense training and injury. 
Other anabolic hormones, such as insulin and insulin-
like growth factor-I, are often stacked together with 
androgens and growth hormone. Despite risks of 
unsupervised use, performance enhancers are used 
because they work.
In recent years, common use of such agents has 
resulted in world and Olympic records being broken at 
an unprecedented pace by superhuman athletes. For 
athletic applications, eﬀ ective dosing and timing have 
been worked out. Medical use of these agents, outside 
the burn unit [16,17], has been quite rare in the ICU 
setting. Further research is therefore needed to optimize 
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the use of these agents to help our patients recover from 
the ultimate race – critical illness. In a sense, evolving to 
survive critical illness and to function again normally 
would be superhuman, and we should learn from athletes 
who perform superhuman feats daily to help our patients 
recover from what Mother Nature would have previously 
deemed unrecoverable.
Idea
Use well-timed nutritional and hormonal interventions 
to improve immunological and neuromuscular responses 
so as to aid healing and prevent debility. Use high-dose 
protein (1.5 to 2.0 g/kg/day), exercise (that is, early ambu-
lation of ventilated patients), and hydroxymethyl butyrate 
during the acute phase, with no potent anabolics. In the 
later phases, use suﬃ  cient calories and high-quality 
protein, β-blockers, and hydroxymethyl butyrate comple-
mented by oxandrolone and creatine. In the recovery 
phase, add low doses of growth hormone to this pres-
cription. (Following the acute phase of burns, approaches 
using β-blockers and oxandrolone have been quite 
success ful, provided that early and adequate protein/
calorie delivery is achieved [16,17].) Delivering suﬃ  cient 
calories and protein in the chronic and recovery phases 
of critical illness is mandatory if oxandrolone, growth 
hormone, or other anabolic agents are to be both safe and 
eﬀ ective.
After rescue, we should adapt patients to their 
critical illness physiology 
(J Marini)
Background
Critical care evolved from anesthetic approaches and 
postoperative practice. In elective cases, the sudden 
trauma of surgery interrupts resting physiology and is 
addressed by an attempt to restore a normal baseline. In 
the critical care setting, however, the price of maintaining 
normality may be injury inﬂ icted by the therapy itself 
(ventilator-induced lung injury, drug toxicity, conse-
quences of sedation, and so forth). Equally plausible is 
that our enforcing of normal indicators and protracted 
use of excessive support may impede the patient’s poten-
tial to adapt to the abnormal physiology that charac-
terizes chronic critical illness.
Health is characterized by gradual transitions between 
physiological states, by variation of cardiorespiratory 
indices, and by continual adaptation to biochemical, 
environ mental, and mechanical stressors. Acute disease, 
on the contrary, is often characterized by abrupt transi-
tions, failure to adapt to the stressor, and monotonously 
inﬂ exible physiological patterns [18]. Currently, our 
treatments rescue very eﬀ ectively, but when sustained for 
too long they may frustrate the patient’s innate 
adaptability to stressful but potentially survivable illness. 
For example, early use of short-term muscle relaxants 
enables lung-protective strategies and may reduce 
mortality risk in acute respiratory distress syndrome [19], 
but when sustained for too long muscle relaxants can 
cause muscular atrophy and sustained weakness [20]. 
Because evolution did not provide for appropriate 
responses to severe acute injuries, an argument can be 
made that we must moderate the initial assault and 
response, and then build our capability to respond to 
lingering challenges over time.
During health, tolerable stresses above the resting 
baseline that are applied and released build strength, 
promote tolerance, and remodel tissues. Endurance 
athletes are a good example of what can be achieved with 
intermittent exposure to challenging stress. Stress-
induced adaptations include enhanced pulmonary oxy-
gen exchange, increased blood volume and hemo globin 
concentration, enriched blood ﬂ ow to skeletal muscle, 
improved thermal regu lation, increased mitochondrial 
size and density, and increased capillarization of 
muscular beds. Th e healthy individual is also extremely 
adaptable when the physio logic milieu is gradually 
changed. Important lessons regarding adaptation to 
abnormal physiology have been learned from protracted 
exposure to hypoxic inspired gas, both in mountain 
climbing and in the experimental laboratory [21].
Functionally adaptive response needs some time to 
develop. For example, after exposure to a thermal stress, 
heat shock proteins require approximately 18 hours to be 
expressed to a level that protects against experimental 
ventilator-induced lung injury and sepsis [22]. Conver-
sely, abrupt and synchronous exposure to the same high 
temperature may accelerate ventilator-induced lung 
damage, whereas cooling inhibits its expression [23]. 
Slowly achieving a given target is protective in other 
settings. For example, impressive depths of hypoxemia 
can be tolerated and the dangers of hyperoxia avoided by 
graded exposure to permissive hypoxemia [24]. Th e 
amplitude and timing of these conditioning challenges to 
the resting baseline and to the intermittent stresses are 
keys to tolerance and adaptation. Important unanswered 
questions related to conditioning of the critically ill 
patient relate to whether injured tissues are capable of 
stress conditioning and when in the course of the illness 
is it advisable to time the ﬂ ip from the full support of 
rescue to a goal-directed conditioning pattern.
Idea
A two-stage approach of initial rescue – that emphasizes 
minimizing demand, full support, gentle transitions, and 
assuming physiological control – followed by an adaptive 
phase  – characterized by ongoing targeted reduction of 
vital supports and imposed intermittent stresses and rest 
periods, akin to the endurance and strength-building 
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programs of athletic training – should be applied. (Such 
acclimatization and conditioning might be applied to the 
most common and unchallenged elements of acute care, 
such as the fraction of inspired oxygen, ventilating 
pressures, vaso pressors, and positioning.) Expressed 
poetically: ‘First shelter the critically ill patient during the 
storm and then teach the patient to dance in the rain.’
Limit lung dishomogeneity to prevent lethal injury 
by the ventilator 
(L Gattinoni)
Background
Awareness of the potential for ventilator-caused lung 
damage has grown over the past 25 years. Clinicians now 
appreciate that excessive airway pressures are dangerous, 
particularly when large tidal volumes are employed and 
insuﬃ  cient positive end-expiratory pressure is used to 
keep the lung from experiencing high-pressure tidal 
opening and collapse cycles [25]. Th e healthy portions of 
the injured lungs have relatively normal mechanical 
properties [26]. A ﬁ xed tidal volume crammed into a 
smaller lung will accentuate stress and strain. Th e 
clinically measurable correlates of resting lung volume 
and stretched lung volume are the functional residual 
capacity and the combination of the volume attributable 
to positive end-expiratory pressure and tidal volume [27].
Normal lungs begin to lose their integrity, however, 
when the gas volume of the given sector exceeds its 
resting value by a factor of 2.0 to 2.5. Such an extreme 
expansion of dimensional sizes is rarely seen in uniform 
lungs in the clinical setting [28]. However, inter depen-
dence ampliﬁ es local forces at the interface between open 
tissue and collapsed tissue, a concept ﬁ rst brought to 
attention more than four decades ago in the work of 
Mead, Takashima, and Leith [29]. At these stress riser 
points, the alveolar–capillary membrane can be stressed 
suﬃ  ciently to break down. When this membrane does 
break down, the rate of deterioration occurs with 
impressive speed – presumably because new stress risers 
are generated and the aerated lung size shrinks. Th e 
relatively poor correlation across diﬀ erent patient 
populations between tidal volume and outcome, even 
when the latter is adjusted to predicted body weight, 
perhaps occurs for these reasons. If the number of stress 
riser points can be minimized, therefore, the lung will be 
better protected and catastrophic progression of lung 
injury may be avoided or slowed.
Idea
Promote uniformity and minimize the generation of 
stress rising points of heterogeneity by measures such as 
prone positioning (which reduces the gradient of 
transalveolar pressure) and recruiting the lung. 
Monitoring of the injured lung should be conducted with 
methods that are sensitive to regional heterogeneity  – 
such as computed tomography and possibly electrical 
impedance tomography, ultrasound, and acoustic map-
ping – rather than exclusively by the global methods for 
monitoring lung mechanics and gas exchange in use today.
Targeting the microcirculation to improve outcome 
(C Ince)
Background
Tissue health depends on adequacy of perfusion and 
oxygenation, not always well reﬂ ected by global measures 
of cardiac output and oxygen extraction. In the setting of 
sepsis, the endothelium and vasculature are under assault 
by activated leukocytes, inﬂ ammatory mediators, and 
reactive oxygen species that cause microcirculatory 
dysfunction in advance of organ failure [30]. A com-
promised microcirculation is no longer able to regu late 
blood ﬂ ow distribution, resulting in functional shunting 
where the oxygen need of the parenchymal cells is not 
met by adequate delivery [31]. Th is condition describes 
distributive shock, one of the four states of shock deﬁ ned 
by Weil and Shubin [32]. Early restoration of perfusion 
and oxygenation in addition to correction of the 
imbalances set into motion by endo thelial damage, 
inducible nitric oxide synthase, endo the lial nitric oxide 
synthase, and reactive oxygen species appear to improve 
outcomes [33]. Measures to reopen the microcirculation 
include boosting of hematocrit and oxygen transport, 
increasing the intravascular volume, and control of 
oxidative stress and inﬂ ammatory load.
An extensive body of scientiﬁ c data collected in an 
experimental setting documents such complex bio-
chemical interplay. Clinical data demonstrate that early 
interventions targeting increased global perfusion improve 
outcomes and lower Sequential Organ Failure Assess-
ment scores. Although the value of such an approach has 
been established for surgical patients, whether inter-
ventional targeting works as successfully for critically ill 
septic patients remains controversial. Th e ultimate 
objective, however, is to oxygenate the microcirculation 
by improved perfusion with blood that is optimally 
charged to oﬀ -load oxygen by maintaining adequate 
circulatory dimensions, ﬁ ne-tuned vasoregulation, and 
improved plasmatic composition. Th e latter objective 
could conceivably be helped by using balanced starches 
to promote convection and correct hypovolemia. Blood 
transfusions, in addition to increasing oxygen-carrying 
capacity, also recruit previously unﬁ lled capillaries and 
shorten diﬀ usion distances, thereby promoting oxygen 
transport to tissue [34]. To reverse the consequences of 
the shock cascade, optimal perfusion must be accom-
plished at the local microcirculatory level, not simply by 
improving the performance of the heart and charging the 
blood with high oxygen content.
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In recent years, a variety of techniques that monitor 
microscopic blood ﬂ ow and its consequences have been 
employed in the laboratory setting. Th ese have been 
brought closer to readiness for clinical implementation 
[35]. With such technology, the potential eﬃ  cacy or 
adverse consequences of drugs and ﬂ uids can be 
monitored in representative tissue beds. Th e tools used 
to implement a new paradigm based on controlling 
inﬂ ammation, resuscitating endothelial cells, and 
modulating reactive oxygen species will require such 
monitoring instruments.
Idea
Target the microcirculation as the primary objective. 
Directly visualize representative microcirculatory beds to 
monitor progress toward the goal of achieving adequate 
perfusion and oxygenation. Utilize the drugs and ﬂ uids 
that are eﬀ ective in oxygenating and perfusing the 
microcirculation (goal-directed ﬂ uid therapy plus blood 
transfusion), opening the microcirculation (for example, 
sodium nitrite, a pure nitric oxide donor with potential 
for releasing nitric oxide from hypoxic red blood cells in 
compromised tissues), preserving the cellular glycocalyx 
(for example, vitamin C), and providing potent actions at 
the microcirculatory level.
Employ holistic care to take advantage of a missed 
opportunity 
(TJ Gan)
Background
As practiced in advanced industrial societies, western 
medicine leverages scientiﬁ cally-based therapies that 
emphasize artiﬁ cial procedures and drugs. ICU medicine 
has been an avid proponent of management that stresses 
measurement and correction. Traditional eastern 
practices, on the contrary, embrace a variety of treat-
ments that integrate complementary and alternative 
measures (CAM) into a less methodically documented 
holistic approach that conceives of health as a tuned 
balance of body, mind, and spirit. In recent years, the 
importance of engaging these missing spheres has also 
been recognized in the outpatient practices of the 
advanced industrial world. Diet, exercise, relaxation, 
massage, prayer, music, and closer involvement of the 
family – methods that are outside established standards 
for ICU practice – have increasingly been integrated into 
intensive care management settings [36-38]. In the 
outpatient environment, CAM have been recognized as 
helpful in relieving stress, anxiety, discomfort, restless-
ness, and insomnia. Th e existing literature strongly backs 
the eﬀ ectiveness of CAM for attenuating pain and 
anxiety; patients have generally been receptive and 
ultimately satisﬁ ed with their use [39-41]. Demands for 
inpatient application of CAM are increasingly strong, as 
they confer a measure of treatment control to the patient 
and family, and emphasize patient well-being and 
preferences during their hospital stay. Where imple-
mented in the inpatient setting, CAM methodology has 
been viewed as clinically eﬀ ective by patients and 
physicians alike [38].
Th e patient with critical illness faces major problems 
related to sleep, anxiety, and pain [40,41]. Th ese 
challenges are severe enough to warrant sedation and 
analgesia in doses that may ultimately compromise pro-
gress or cause complications. Recovery may be slow and 
arduous. CAM methodology is generally free of lasting 
consequences other than lingering relaxation and 
reduced pain. Acknowledging a strong recent emphasis 
on avoiding delirium, a holistic approach is an attractive 
option to complement our current measures for intensive 
care [42].
Idea
Wake patients earlier, use fewer drugs, and incorporate 
CAM into ICU practice of the alert and semiconscious 
patient. Use these techniques routinely to accomplish 
eﬀ ective sleep, pain relief, and the sense of well-being 
that will accelerate rehabilitative progress and reduce the 
consequences of drug-based management.
Conclusion
Th e future of critical care medicine will be shaped not 
only by the evidence-validated foundations of science, 
but by innovations based on unproven and, in many 
cases, untested concepts and thoughtful visions of 
scientists and clinicians familiar with the complex 
problems actually faced in clinical practice. On occasion, 
an innovative paradigm shift fostered by a novel idea can 
reorient the forces of academic investigation to generate 
an evidence base upon which such concepts and 
interpretations can ﬁ nd scientiﬁ c justiﬁ cation. Intriguing 
as this out-of-the-box thinking may be, however, such 
visions should not be implemented until supported by a 
substantial body of basic and clinical research.
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